Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes

Journal:

Journal of Clinical Investigation

Published:

2025-09-30

DOI:

10.1172/jci176403

Affiliations:

7

Authors:

15

Go to article

Institutions	Authors	Share
Catholic University of Leuven (KU Leuven), Belgium	10.000000 10.000000	0.67
Benaroya Research Institute at Virginia Mason (BRI), United States of America (USA)	2.000000	0.13
VIB-KU Laboratory of Translational Genetics, Belgium	1.000000	0.07
Flanders Institute for Biotechnology (VIB), Belgium	1.000000	0.07
Immune Tolerance Network (ITN), United States of America (USA)	0.500000	0.03
University of California, San Francisco (UCSF), United States of America (USA)	0.500000	0.03

Interested in Immunology?